Significant Ownership of Funicular Funds, LP
- Signature - Title
- Jacob Ma-Weaver - Managing Member of the General Partner
- Location
- San Francisco, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Funicular Funds, LP.
Follow Filing Activity
Follow Funicular Funds, LP and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Funicular Funds, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NETD | Nabors Energy Transition Corp. II | Class A Ordinary Shares, $0.0001 par value | 56% | $30,739,247 | -$5,103,000 | 2,710,692 | -14% | Funicular Funds, LP | 17 Nov 2025 |
| SYBX | SYNLOGIC, INC. | Common Stock, par value $0.001 per share | 28% | $1,987,331 | 3,312,219 | Funicular Funds, LP | 02 Apr 2026 | ||
| ATCH | AtlasClear Holdings, Inc. | Common Stock, par value $0.0001 per share | 9.9% | $9,248,539 | +$8,750,331 | 12,669,232 | +1756% | Funicular Funds, LP | 10 Oct 2025 |
| KTTA | Pasithea Therapeutics Corp. | Common Stock, par value $0.0001 | 7.4% | $1,416,424 | 1,839,512 | Funicular Funds, LP | 15 Apr 2026 | ||
| IMA | ImageneBio, Inc. | Common Stock, $0.001 par value | 5.8% | $4,211,322 | 643,933 | Funicular Funds, LP | 29 Dec 2025 | ||
| AMWL | American Well Corp | Class A Common Stock, par value $0.01 | 5.5% | $3,951,436 | 810,551 | Funicular Funds, LP | 16 Jan 2026 | ||
| ABEO | ABEONA THERAPEUTICS INC. | Common Stock, par value $0.01 | 5.3% | $14,916,352 | 3,007,329 | Funicular Funds, LP | 27 Mar 2026 | ||
| NSRX | Nasus Pharma Ltd | Ordinary Shares | 5.2% | $3,309,730 | 612,913 | Funicular Funds, LP | 31 Mar 2026 | ||
| ACOG | Alpha Cognition Inc. | Common Stock, no par value | 5.1% | $6,632,745 | +$324,483 | 1,114,747 | +5.1% | Funicular Funds, LP | 11 Feb 2026 |
Schedules 13D/G Reported by Funicular Funds, LP:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.